Vitamin D-metabolizing enzyme CYP24A1 affects oncogenic behaviors of oral squamous cell carcinoma and its prognostic implication
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Low vitamin D-metabolizing enzyme CYP24A1 expression promotes oral cancer growth and reduces patient survival. This finding highlights CYP24A1 as a potential biomarker and therapeutic target in oral squamous cell carcinoma (OSCC).
Area Of Science
- Biochemistry
- Oncology
- Molecular Biology
Background
- Vitamin D is crucial for cellular functions and homeostasis.
- Dysregulation of the vitamin D-metabolizing enzyme CYP24A1 is implicated in various human cancers.
- The role of CYP24A1 in oral malignancy is not fully understood.
Purpose Of The Study
- To investigate the pathological relevance of CYP24A1 expression in oral squamous cell carcinoma (OSCC).
- To determine the impact of CYP24A1 on OSCC cell behavior and patient prognosis.
Main Methods
- Studied the effects of CYP24A1 suppression and knockout on OSCC cell proliferation, invasion, and colony formation in vitro.
- Assessed tumor growth in vivo following CYP24A1 manipulation.
- Utilized RNA-sequence analysis for gene clustering.
- Correlated CYP24A1 expression levels with patient survival data.
Main Results
- Suppression of CYP24A1 increased OSCC cell proliferation, invasion, colony formation, and tumor growth.
- CYP24A1 knockout inhibited cell death induced by fluorouracil and cisplatin.
- RNA-sequence analysis linked MYC signaling to CYP24A1-mediated oncogenic behaviors.
- Decreased CYP24A1 expression was found in 61% of OSCC cases and associated with shorter survival.
Conclusions
- Low CYP24A1 expression promotes oncogenic activity in OSCC.
- Reduced CYP24A1 levels are significantly associated with poor prognosis in oral cancer patients.
- CYP24A1 represents a potential prognostic biomarker and therapeutic target for OSCC.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...